Results 261 to 270 of about 216,249 (293)
Some of the next articles are maybe not open access.
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
Nature Reviews Clinical Oncology, 2016Celine Boutros +2 more
exaly
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Nature Reviews Drug Discovery, 2012Andrew J Brown +2 more
exaly
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Nature Reviews Clinical Oncology, 2023exaly
Evolution of strategies to improve preclinical cardiac safety testing
Nature Reviews Drug Discovery, 2016Gary Gintant, Norman Stockbridge
exaly

